henhaobio
Sign in

bioRxivPharmacology & Toxicology

Soluble adenylyl cyclase inhibition prevents human sperm functions essential for fertilization

M. Balbach, L. Ghanem, T. Rossetti, N. Kaur, C. Ritagliati, J. Ferreira, D. Krapf, L. Puga, C. Santi, J. N. Hansen, D. Wachten, M. Fushimi, P. T. Meinke, J. Buck, L. R. Levin

PDFDOIPreprint

Abstract

Soluble adenylyl cyclase (sAC: ADCY10) is essential for activating dormant sperm. Studies of freshly dissected mouse sperm identified sAC as needed for initiating capacitation and activating motility. We now use an improved sAC inhibitor, TDI-10229, for a comprehensive analysis of sAC function in human sperm. Unlike dissected mouse sperm, human sperm are collected post-ejaculation, after sAC activity has already been stimulated. Even in ejaculated human sperm, TDI-10229 interrupts stimulated motility and capacitation, and it prevents acrosome reaction in capacitated sperm. At present, there are no non-hormonal, pharmacological methods for contraception. Because sAC activity is required post-ejaculation at multiple points during the sperms journey to fertilize the oocyte, sAC inhibitors define candidates for non-hormonal, on-demand contraceptives suitable for delivery via intravaginal devices in females.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.